

From Kanagawa to Kendall Square: iPS Cells, Wearable Cyborgs, and the Science of ME-BYO
Join the Kanagawa Prefectural Government and the Consulate-General of Japan in Boston at CIC Cambridge for an afternoon of regenerative medicine, medical robotics, and a new science of staying healthy — direct from Japan's life science gateway.
A decade ago, facing the world's most rapidly aging society, Kanagawa made an unusual bet. Instead of treating health and disease as binary, its Healthcare New Frontier policy built an entire innovation ecosystem around the concept of ME-BYO, the measurable continuum between the two, where intervention is earliest, cheapest, and most effective.
The results now speak Kendall Square's language. One of the world's first iPS cell-based clinical trials for subacute spinal cord injury, completed at Keio University. The wearable cyborg HAL, in clinical use from Tsukuba to the US and worldwide. Dynamic Chest X-ray technology, brought from concept to market through a decade of corporate-sponsored research at Brigham and Women's Hospital, sparked by a Kanagawa initiative. And two thriving landing pads for global collaboration: KING SKYFRONT in Kawasaki and Shonan iPark, where nearly 300 life science companies and institutions already work side by side.
The researchers, physicians, and executives behind each of these programs will be in the room on July 21st, alongside Governor Yuji Kuroiwa (To Be Confirmed). Stick around after the formal program for open networking with the full delegation.
Coffee and snacks will be provided.
Hosted by Kanagawa Prefectural Government
Supported by the Consulate-General of Japan in Boston and CIC Japan Desk
======
Agenda
1:30 Doors Open – Registration/Networking Over Coffee
2:00 Program Start
Welcome Remarks by the Consul General of Japan in Boston
Consul General Seiichiro Takahashi, Consulate-General of Japan in Boston
PART I: Healthcare New Frontier Initiatives
Healthcare New Frontier and Beyond
Yuji Kuroiwa, Governor of Kanagawa Prefecture (TBC)
Initiatives of ME-BYO and the School of Health Innovation
Yuichi Tei/Ung-il Chung, MD, PhD, Vice President and Dean, School of Health Innovation, Kanagawa University of Human Services
PART II: Innovation Hub Initiatives
Collaboration at the Tonomachi Innovation Hub, KING SKYFRONT
Ryuta Nomura, Chairman of the Board and CEO, Central Institute for Experimental Medicine and Life Science (CIEM)
Building a Biopharmaceutical Ecosystem at Shonan iPark
Toshio Fujimoto, MD, MBA, CEO, iPark Institute Co., Ltd.
Q&A/Coffee Break
PART III: Global Innovation Technologies
Research and Development of Regenerative Medicine Using iPS Cells for Spinal Cord Injury in Japan
Masaya Nakamura, MD, PhD, Professor & Chair, Department of Orthopaedic Surgery, Keio University School of Medicine
Dynamic Chest X-ray (DXR) from Research and Development to the Market: A Decade of Corporate-Sponsored Research at Brigham and Women's Hospital Triggered by the Kanagawa Initiative by Governor Kuroiwa
Hiroto Hatabu, MD, PhD, Professor of Radiology, Emeritus, Harvard Medical School
Healthcare Innovation with Wearable HAL
Yoshihiro Yasunaga, PhD, Executive Officer of Sales and Marketing, CYBERDYNE Inc., CEO, ROBOCARE Center Group
Q&A/Open Networking
4:00 Program End